Faculty of Health Sciences

Could a drug combination prevent people with the eye disease uveitis lose their sight?

Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU).

Launch of new neurodevelopmental and neurodiversity network

A new regional network between the GW4 universities of Bath, Bristol, Cardiff and Exeter has launched which will focus on research into neurodiversity and conditions such as ADHD and autism. It will draw on world-leading expertise across GW4, including the MRC Integrative Epidemiology Unit at Bristol, the Wales Autism Research Centre at Cardiff, and Egenis research groups at Exeter. While supported by GW4 – a research alliance bringing together the four universities - the network hopes to generate engagement from other researchers, clinicians, the public, and third sector organisations from around the region.